by Mark Chiang

马克·蒋

Share To

分享到

Sanofi has announced an expansion of its Insulins Valyou Savings Program, which will now provide a 30-day supply of any Sanofi insulin for $35 to all patients in the United States with a valid prescription. The pharmaceutical company revealed the updated program on September 26, stating that it aims to improve access and affordability for individuals managing diabetes.

赛诺菲宣布扩大其胰岛素Valyou储蓄计划，现在所有持有有效处方的美国患者都可以以35美元的价格获得30天用量的任何赛诺菲胰岛素。这家制药公司于9月26日公布了更新后的计划，称此举旨在改善糖尿病患者获取和负担胰岛素的能力。

This initiative extends the program’s reach beyond its original focus on uninsured patients, making it available to anyone prescribed Sanofi insulin products..

该举措扩展了项目的覆盖范围，超越了最初针对无保险患者的重点，使得任何被处方使用赛诺菲胰岛素产品的人都能获得这项服务。

The expanded program applies to all Sanofi insulin offerings and is accessible nationwide. Patients can enroll regardless of their insurance status or income level, provided they have a valid prescription. The company emphasized that this flat-rate pricing structure is designed to simplify costs and reduce financial barriers for those requiring insulin therapy..

这项扩展项目适用于所有赛诺菲胰岛素产品，并在全国范围内均可获取。患者只要有有效处方，无论其保险状况或收入水平如何，都可以注册参与。公司强调，这种固定价格结构旨在简化费用，降低需要胰岛素治疗的人群的经济障碍。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

For any suggestion and feedback, please contact us.

如果有任何建议和反馈，请联系我们。

Date: September 26, 2025

日期：2025年9月26日

Related posts:

相关文章:

Biosimilar Approvals Face Complex Path: Comparative Trials and Surrogate Endpoints Key for FDA and EMA Compliance

生物仿制药审批面临复杂路径：比较试验和替代终点是FDA和EMA合规的关键

PAK5 Protein Identified as Potential Contributor to Trastuzumab Emtansine Resistance in HER2-Positive Breast Cancer

PAK5蛋白被确定为HER2阳性乳腺癌中曲妥珠单抗Emtansine耐药的潜在因素

Cilta-cel CAR T-Cell Therapy Achieves Five-Year Progression-Free Survival in Relapsed Multiple Myeloma

Cilta-cel CAR T细胞疗法在复发性多发性骨髓瘤中实现五年无进展生存率

Study Links Healthy Vitamin D Levels to Reduced COVID-19 Hospitalization Risk

研究发现：健康的维生素D水平可降低COVID-19住院风险

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

电子邮件地址

Author

作者

Mark Chiang

马克·蒋

Related Post

相关文章

News Flash

新闻快讯

Accuray Introduces All-in-One Radiotherapy System for Adaptive Cancer Treatment

Accuray推出用于自适应癌症治疗的全方位放射治疗系统

2025-09-26

2025年9月26日